With the Singh brothers of Ranbaxy being arrested over allegations of financial fraud, Scrip looks at the history of issues at the company and how things appear headed even further downhill with Daiichi Sankyo also separately pursuing enforcement of damages against the brothers.
Author: Informa Pharma Intelligence
Published: 02 September 2019
Number of pages:3
Brothers, Shivinder Singh and Malvinder Singh who once owned the leading Indian Drug firm, Ranbaxy Laboratories Ltd., were arrested by the Economic Offences Wing of the Delhi Police following complaints of misappropriation of finances estimate at more than INR23bn ($338m). The actions took place at Religare Finvest Ltd, the financial arm of Religare Enterprises which the brothers founded. Scrip looks at the long history of accusations and charges against the brothers, the crippling effect on the company’s brand, and details about the most recent charges of misappropriation of funds.
Datamonitor Healthcare is part of Pharma intelligence
Datamonitor Healthcare is a trading division of Datamonitor Limited, a company registered in England and Wales with company number 2306113 whose registered office is 5 Howick Place, London, SW1P 1WG. VAT GB365462636. Datamonitor Limited is part of Informa PLC.
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726